Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, Indiana.
Ancestry, Lehi, Utah.
Protein Sci. 2020 Feb;29(2):350-359. doi: 10.1002/pro.3777. Epub 2019 Nov 21.
Most signal transduction pathways in humans are regulated by protein kinases through phosphorylation of their protein substrates. Typical eukaryotic protein kinases are of two major types: those that phosphorylate-specific sequences containing tyrosine (90 kinases) and those that phosphorylate either serine or threonine (395 kinases). The highly conserved catalytic domain of protein kinases comprises a smaller N lobe and a larger C lobe separated by a cleft region lined by the activation loop. Prior studies find that protein tyrosine kinases recognize peptide substrates by binding the polypeptide chain along the C-lobe on one side of the activation loop, while serine/threonine kinases bind their substrates in the cleft and on the side of the activation loop opposite to that of the tyrosine kinases. Substrate binding structural studies have been limited to four families of the tyrosine kinase group, and did not include Src tyrosine kinases. We examined peptide-substrate binding to Src using paramagnetic-relaxation-enhancement NMR combined with molecular dynamics simulations. The results suggest Src tyrosine kinase can bind substrate positioning residues C-terminal to the phosphoacceptor residue in an orientation similar to serine/threonine kinases, and unlike other tyrosine kinases. Mutagenesis corroborates this new perspective on tyrosine kinase substrate recognition. Rather than an evolutionary split between tyrosine and serine/threonine kinases, a change in substrate recognition may have occurred within the TK group of the human kinome. Protein tyrosine kinases have long been therapeutic targets, but many marketed drugs have deleterious off-target effects. More accurate knowledge of substrate interactions of tyrosine kinases has the potential for improving drug selectivity.
在人类中,大多数信号转导途径通过其蛋白质底物的磷酸化被蛋白激酶调节。典型的真核蛋白激酶有两种主要类型:一种是磷酸化含有酪氨酸的特定序列的激酶(约 90 种),另一种是磷酸化丝氨酸或苏氨酸的激酶(约 395 种)。蛋白激酶的高度保守催化结构域由较小的 N lobe 和较大的 C lobe 组成,两者由激活环的裂隙区域隔开。先前的研究发现,蛋白酪氨酸激酶通过结合激活环一侧的 C lobe 上的多肽链来识别肽底物,而丝氨酸/苏氨酸激酶则在裂隙中和与酪氨酸激酶相对的激活环的一侧结合其底物。底物结合结构研究仅限于酪氨酸激酶组的四个家族,不包括 Src 酪氨酸激酶。我们使用顺磁弛豫增强 NMR 结合分子动力学模拟研究了 Src 与肽底物的结合。结果表明,Src 酪氨酸激酶可以结合底物定位残基,其位置在磷酸受体残基的 C 末端,与丝氨酸/苏氨酸激酶的结合方式相似,与其他酪氨酸激酶不同。突变分析证实了这种新的酪氨酸激酶底物识别观点。在人类激酶组中,可能不是酪氨酸和丝氨酸/苏氨酸激酶之间的进化分裂,而是底物识别发生了变化。蛋白酪氨酸激酶一直是治疗的靶点,但许多上市药物具有有害的脱靶效应。更准确地了解酪氨酸激酶的底物相互作用有可能提高药物的选择性。